Clinical Hospital Center Split

Split HR-21000

1 studies enrolling now · 3 studies all time

What they study most

Alzheimer Disease, Ischemic Stroke; Ischemic Attack, Transient, Ulcerative Colitis

Studies at this site

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1) — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Phase 2 Dose-finding IMU-838 for Ulcerative Colitis — Stopped early